List of Tables
Table 1. Global Inactivated Influenza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Inactivated Influenza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Inactivated Influenza Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Inactivated Influenza Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Inactivated Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Inactivated Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inactivated Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Inactivated Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Inactivated Influenza Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Inactivated Influenza Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Inactivated Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Inactivated Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Inactivated Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Inactivated Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Inactivated Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Inactivated Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Inactivated Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Inactivated Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Inactivated Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Inactivated Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Inactivated Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Inactivated Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Inactivated Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inactivated Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Inactivated Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Inactivated Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Inactivated Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Inactivated Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Inactivated Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Inactivated Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Inactivated Influenza Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Inactivated Influenza Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Inactivated Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Inactivated Influenza Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Inactivated Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Inactivated Influenza Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Inactivated Influenza Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Inactivated Influenza Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Inactivated Influenza Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Inactivated Influenza Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Inactivated Influenza Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Inactivated Influenza Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Inactivated Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Inactivated Influenza Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Inactivated Influenza Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Inactivated Influenza Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. CSL Limited Company Information
Table 71. CSL Limited Description and Business Overview
Table 72. CSL Limited Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSL Limited Inactivated Influenza Vaccine Product
Table 74. CSL Limited Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK Inactivated Influenza Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Pasteur Company Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Pasteur Inactivated Influenza Vaccine Product
Table 84. Sanofi Pasteur Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Viatris Inactivated Influenza Vaccine Product
Table 89. Viatris Recent Developments/Updates
Table 90. Hualan Biological Company Information
Table 91. Hualan Biological Description and Business Overview
Table 92. Hualan Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Hualan Biological Inactivated Influenza Vaccine Product
Table 94. Hualan Biological Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. AstraZeneca Inactivated Influenza Vaccine Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Sinovac Biotech Company Information
Table 101. Sinovac Biotech Description and Business Overview
Table 102. Sinovac Biotech Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sinovac Biotech Inactivated Influenza Vaccine Product
Table 104. Sinovac Biotech Recent Developments/Updates
Table 105. Aleph Biomedical Company Information
Table 106. Aleph Biomedical Description and Business Overview
Table 107. Aleph Biomedical Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Aleph Biomedical Inactivated Influenza Vaccine Product
Table 109. Aleph Biomedical Recent Developments/Updates
Table 110. Abbott Laboratories Company Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Abbott Laboratories Inactivated Influenza Vaccine Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Novartis International Company Information
Table 116. Novartis International Description and Business Overview
Table 117. Novartis International Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Novartis International Inactivated Influenza Vaccine Product
Table 119. Novartis International Recent Developments/Updates
Table 120. Changchun Institute of Biological Company Information
Table 121. Changchun Institute of Biological Description and Business Overview
Table 122. Changchun Institute of Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Changchun Institute of Biological Inactivated Influenza Vaccine Product
Table 124. Changchun Institute of Biological Recent Developments/Updates
Table 125. BCHT Company Information
Table 126. BCHT Description and Business Overview
Table 127. BCHT Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. BCHT Inactivated Influenza Vaccine Product
Table 129. BCHT Recent Developments/Updates
Table 130. Jiangsu GDK Company Information
Table 131. Jiangsu GDK Description and Business Overview
Table 132. Jiangsu GDK Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Jiangsu GDK Inactivated Influenza Vaccine Product
Table 134. Jiangsu GDK Recent Developments/Updates
Table 135. KM Biologics Company Information
Table 136. KM Biologics Description and Business Overview
Table 137. KM Biologics Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. KM Biologics Inactivated Influenza Vaccine Product
Table 139. KM Biologics Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Inactivated Influenza Vaccine Distributors List
Table 143. Inactivated Influenza Vaccine Customers List
Table 144. Inactivated Influenza Vaccine Market Trends
Table 145. Inactivated Influenza Vaccine Market Drivers
Table 146. Inactivated Influenza Vaccine Market Challenges
Table 147. Inactivated Influenza Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Influenza Vaccine
Figure 2. Global Inactivated Influenza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inactivated Influenza Vaccine Market Share by Type: 2024 & 2031
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Inactivated Influenza Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Inactivated Influenza Vaccine Market Share by Application: 2024 & 2031
Figure 8. Children
Figure 9. Adolescence
Figure 10. Adults
Figure 11. Elderly
Figure 12. Global Inactivated Influenza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Inactivated Influenza Vaccine Market Size (2020-2031) & (US$ Million)
Figure 14. Global Inactivated Influenza Vaccine Sales (2020-2031) & (K Units)
Figure 15. Global Inactivated Influenza Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 16. Inactivated Influenza Vaccine Report Years Considered
Figure 17. Inactivated Influenza Vaccine Sales Share by Manufacturers in 2024
Figure 18. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Inactivated Influenza Vaccine Players: Market Share by Revenue in Inactivated Influenza Vaccine in 2024
Figure 20. Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Inactivated Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Inactivated Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 23. North America Inactivated Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Inactivated Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 27. Europe Inactivated Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 28. Germany Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Inactivated Influenza Vaccine Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Inactivated Influenza Vaccine Revenue Market Share by Region (2020-2031)
Figure 35. China Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Inactivated Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 46. Latin America Inactivated Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Inactivated Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Inactivated Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Inactivated Influenza Vaccine by Type (2020-2031)
Figure 56. Global Revenue Market Share of Inactivated Influenza Vaccine by Type (2020-2031)
Figure 57. Global Inactivated Influenza Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Inactivated Influenza Vaccine by Application (2020-2031)
Figure 59. Global Revenue Market Share of Inactivated Influenza Vaccine by Application (2020-2031)
Figure 60. Global Inactivated Influenza Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 61. Inactivated Influenza Vaccine Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
